[EN] INHIBITING MONOACYLGLYCEROL LIPASE (MAGL) [FR] INHIBITION DE LA MONOACYLGLYCÉROL LIPASE (MAGL)
摘要:
Provided herein are 1 H-pyrazol-5-yl)-2-azaspiro[3.3]heptan-2-yl methanone compounds substituted with aryl and pyrazolyl moieties, further substituted, for inhibiting rnonoacylglycerol lipase (MAGL), utilized in the treatment of a MAGL-mediated disease or disorder i.e., neurodegenerative diseases, pain, and inflammatory diseases or conditions, as well as cancer, and related methods of making and using the compounds.
[EN] INHIBITING MONOACYLGLYCEROL LIPASE (MAGL) [FR] INHIBITION DE LA MONOACYLGLYCÉROL LIPASE (MAGL)
摘要:
Provided herein are 1 H-pyrazol-5-yl)-2-azaspiro[3.3]heptan-2-yl methanone compounds substituted with aryl and pyrazolyl moieties, further substituted, for inhibiting rnonoacylglycerol lipase (MAGL), utilized in the treatment of a MAGL-mediated disease or disorder i.e., neurodegenerative diseases, pain, and inflammatory diseases or conditions, as well as cancer, and related methods of making and using the compounds.